Zevra Therapeutics, Inc. (NASDAQ:ZVRA) Director Acquires $58,700.00 in Stock
Zevra Therapeutics, Inc. (NASDAQ:ZVRA – Get Free Report) Director John B. Bode bought 10,000 shares of the firm’s stock in a transaction on Friday, July 12th. The stock was purchased at an average cost of $5.87 per share, with a total value of $58,700.00. Following the completion of the transaction, the director now directly owns […]
More Stories
Amedisys, Inc. (NASDAQ:AMED) Shares Purchased by Schonfeld Strategic Advisors LLC
Schonfeld Strategic Advisors LLC lifted its stake in Amedisys, Inc. (NASDAQ:AMED – Free Report) by 17.5% in the 4th quarter,...
Can President Trump Turn Back the Economic Clock? – The New York Times
Can President Trump Turn Back the Economic Clock? The New York Times Can President Trump Turn Back the Economic Clock? The New...
Why oil prices are falling and what it means for the economy – NPR
Why oil prices are falling and what it means for the economy NPR Why oil prices are falling and what it...
Southeast Asia’s Green Economy 2025 Report – Bain & Company
Southeast Asia’s Green Economy 2025 Report Bain & Company Southeast Asia’s Green Economy 2025 Report Bain & Company Related posts: Trump changes...
Trump officials will meet with China, signaling an openness to trade negotiations – CNN
Trump officials will meet with China, signaling an openness to trade negotiations CNN Trump officials will meet with China, signaling an...
How President Trump is reshaping the Justice Department – NPR
How President Trump is reshaping the Justice Department NPR How President Trump is reshaping the Justice Department NPR Related posts: The Tricky...